SEC Comment Letter for HARVARD BIOSCIENCE INC (HBIO) (CIK 0001123494) (HBIO) — Dec 22, 2009

HARVARD BIOSCIENCE INC (HBIO) (CIK 0001123494)
Date: Dec. 22, 2009 · CIK: 0001123494 · Accession: 0000000000-09-071894

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-33957

Date

December 22, 2009

Author

Jeff Jaramillo

Form

UPLOAD

Company

HARVARD BIOSCIENCE INC (HBIO) (CIK 0001123494)

Letter

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 DIVISION OF CORPORATION FINANCE Mail Stop 3030 December 22, 2009 Thomas McNaughton Chief Financial Officer Harvard Bioscience, Inc. 84 October Hill Road Holliston, MA 01746

Re: Harvard Bioscience, Inc. Form 10-K for the Fiscal-Year ended December 31, 2008 Filed March 11, 2009 File No. 001-33957

Dear Mr. McNaughton: We have completed our review of your Form 10-K and related filings and do not, at this time, have any further comments. S i n c e r e l y , Jeff Jaramillo A c c o u n t i n g B r a n c h C h i e f

Show Raw Text

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

       DIVISION OF
CORPORATION FINANCE

Mail Stop 3030           December 22, 2009   Thomas McNaughton Chief Financial Officer Harvard Bioscience, Inc. 84 October Hill Road Holliston, MA 01746

 Re: Harvard Bioscience, Inc.
Form 10-K for the Fiscal-Year ended December 31, 2008
  Filed March 11, 2009
File No. 001-33957

Dear Mr. McNaughton:
  We have completed our review of your Form 10-K and related filings and do not, at this time, have
any further comments.             S i n c e r e l y ,                    Jeff Jaramillo         A c c o u n t i n g  B r a n c h  C h i e f

SecProbe.io